Logo Logo

Author Archives: "Elizabeth Porco"

  1. Home
  2. Author: Elizabeth Porco
  3. Page 48
Elizabeth Porco

Aug 31, 2014
CMSC announces new President & board members
CMSC PR
CMSC Announces New President & Board Members Top MS Organization for Healthcare Professionals Installs Multi-Disciplinary [...]
Elizabeth Porco
Read More
...41
0
Aug 31, 2014
IJMSC features article on the Multiple Sclerosis Self-Management Scale
Partners
International Journal of MS Care Features Article on the Multiple Sclerosis Self-Management Scale (Hackensack, NJ, August 2014)—The [...]
Elizabeth Porco
Read More
...32
0
Aug 24, 2014
AIMS presents the latest on multiple sclerosis treatments
CMSC PR, Partners
AIMS Presents the Latest on Multiple Sclerosis Treatments Educational Programs for Healthcare Professionals Includes Live Events & [...]
Elizabeth Porco
Read More
...39
0
Aug 15, 2014
Biogen Idec’s PLEGRIDY approved in the US for the treatment of multiple sclerosis
INforMS, Partners
Biogen Idec’s PLEGRIDY™(Peginterferon Beta-1a) Approved in the US for the Treatment of Multiple Sclerosis Friday, August 15, 2014 [...]
Elizabeth Porco
Read More
...41
0
Aug 10, 2014
Psychology continuing education credit offered at multiple sclerosis conference
CMSC PR
Psychology Continuing Education Credit Offered At Multiple Sclerosis Conference (Hackensack, NJ, April 2014)—The leading conference [...]
Elizabeth Porco
Read More
...36
0
Jul 31, 2014
Record attendance at the cooperative meeting of CMSC & ACTRIMS
CMSC PR
Record Attendance at the Cooperative Meeting of CMSC & ACTRIMS Leading MS Conference Attracts Top Healthcare [...]
Elizabeth Porco
Read More
...39
0
Jul 23, 2014
PLEGRIDY (Peginterferon beta-1a) approved in the EU for the treatment of multiple sclerosis
INforMS, Partners
PLEGRIDY™ (Peginterferon beta-1a) Approved in the European Union for the Treatment of Multiple Sclerosis Wednesday, July 23, 2014 [...]
Elizabeth Porco
Read More
...37
0
Jul 03, 2014
Teva files citizen petition with the US FDA regarding the complexity of COPAXONE
INforMS, Partners
Teva files Citizen Petition with the U.S. Food and Drug Administration (FDA) regarding the Complexity of COPAXONE® (Glatiramer Acetate) [...]
Elizabeth Porco
Read More
...44
0
Jun 30, 2014
Genzyme’s Lemtrada approved in Argentina for treatment of multiple sclerosis
INforMS, Partners
Genzyme’s Lemtrada Approved in Argentina for Treatment of Multiple Sclerosis Monday, June 30, 2014 8:00 am EDT CAMBRIDGE, [...]
Elizabeth Porco
Read More
...42
0
Jun 16, 2014
Biogen Idec and AbbVie Announce Results from Phase 3 Study Investigating Daclizumab
INforMS, Partners
Biogen Idec and AbbVie Announce Positive Top-Line Results from Phase 3 Study Investigating Daclizumab High-Yield Process in Multiple [...]
Elizabeth Porco
Read More
...34
0
  • (201) 487-1050
  • 3 University Plz Dr Ste 116, Hackensack, NJ 07601
  • info@mscare.org

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us





I have a question about

First

Last




Feel Free To contact Us
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam molestie, tellus id pellen tesque feugiat, sem sem cursus orci, a placerat ante ante nec massa. consectetuer adipiscing elit.

+1-222-333-4444

New York, NY 10123 USA

Mon - Sat 9:00 AM